Skip to main content

Table 3 Bivariate and multivariate logistic regression of ED with predictor variables among diabetic patients in Hawassa city, Jan 2018

From: Erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia

Variable

Erectile Dysfunction

COR(95%CI)

AOR(95%CI

p value

Yes

No

Age

 15–25

3

15

1

1

 

 26–35

16

19

0.04(0.001–0.023)

0.238(0.026–2.168)

0.04

 36–45

46

44

0.002(0.006–0.082)

0.274(0.026–2.84)

 

 45–55

84

18

0.029(0.009–0.098)

0.77(0.072–8.26)

 

 > 55

105

2

2.42(1.73–3.83)

3.2(1.32–4.34)*

 

Occupation

 Unemployed

38

10

1

1

 

 Daily labor

1

4

0.27(0.13–0.69)

1.57(0.095–26.05)

> 0.05

 Merchant

62

16

1.02(0.42–2.47)

3.06(0.299–31.33)

 

 Gov. employee

78

47

0.437(0.199–0.957)

1.03(0.91–11.75)

 

 Private/NGO

26

17

0.402(0.159–1.017)

0.76(0.071–8.26)

 

 Farmer

49

4

1.287(0.473–3.496)

0.6(0.04–9.01)

 

Marital status

 Single

6

19

1

1

 

 Married

233

74

3.5(1.5–8)

7.3(0.937–56.84)

> 0.05

 Divorced

7

3

6(1.21–29.72)

11.13(6.22–67.25)

 

 Widowed

8

2

4.23(2.27–6.32)

1.63(0.952–5.54)

 

Educational status

 No formal education

25

3

1

1

 

 Read and write

43

2

2.3(0.48–11.31)

5.66(0.587–54.84)

> 0.05

 Primary school

51

14

0.556(0.166–1.855)

1.14(0.155–8.46)

 

 High school

70

35

0.32(0.103–0.991)

1.57(0.196–12.71)

 

 College and above

65

44

0.215(0.061–0.76)

3.37(0.346–32.98)

 

Monthly income (Eth.Birr)

 < 500 birr

15

4

1

1

 

 500–1500 birr

114

24

1.6(0.53–4.89)

0.71(0.097–5.32)

> 0.05

 1501–2500 birr

58

32

0.21(0.045–0.99)

0.21(0.025–1.86)

 

 2501–3500 birr

42

25

0.56(0.18–1.75)

0.29(0.032–2.64)

 

 > 3500 birr

25

13

0.612(0.82–2.06)

0.30(0.03–3.03)

 

Residence

 Urban

192

83

1

1

 

 Rural

62

15

1.92(1–3.69)

1.91(0.67–5.5)

> 0.05

Alcohol

 Yes

51

6

0.24(0.093–0.626)

3.23(1.03–10.44)*

0.049

 No

203

92

1

1

 

Smoking

 Yes

15

5

1.19(0.42–3.37)

  

 No

239

93

1

1

> 0.05

Physical exercise

 Yes

44

58

0.167(0.099–0.282)

0.49(0.23–1.09)

 

 No

210

40

1

1

> 0.05

Adherence

 Yes

223

89

0.785(0.369–1.67)

  

 No

31

9

1

1

> 0.05

Type of DM

  Type 1

9

14

1

1

 

 Type 2

245

84

5.1(2.1–12.5)

1.49(0.22–10.06)

> 0.05

Type of hypoglycemic drug

 Oral

133

81

1

1

 

 Injectable

121

17

4.04(2.3–7.06)

5.05(1.15–11.23)

> 0.05

FBS`

 < 126

67

73

1

1

 

 > 126

187

25

8.1(4.78–13.89)

10.3(3.92–27.44)**

0.000

BP

  

1

  

 Normal

35

71

4.06(1.725–9.59)

2.15(0.576–8.07)

 

 Elevated

20

10

14.5(7.15–29.4)

0.80(0.348–1.83)

> 0.05

 Stage1 HTN

98

13

15.3(7.55–30.98)

1.49(0.42–5.29)

 

 Stage2 HTN

101

4

51.2(17.43–150.54)

1

 

BMI

 Underweight

0

0

   

 Normal

128

86

1

1

 

 Overweight

126

12

7.05(0.635–1.82)

 

> 0.05

 Obese

0

0

   

Diabetic duration

 < 5 yrs.

45

59

1

1

 

 5–10 yrs.

102

30

4.45(2.54–7.82)

2.66(1.13–6.27)*

0.025

 > 10 yrs.

107

9

15.5(7.11–34.1)

17.7(6.57–48.01)**

0.001

  1. * Significant at p-value < 0.05. ** Significant at p-value < 0.001